Clinical Research Directory
Browse clinical research sites, groups, and studies.
Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer
Sponsor: Mayo Clinic
Summary
This study explores the potential values of a new blood test approach to detect measurable residual disease or early coming back of cancer (recurrence)/cancer growing, spreading, or getting worse (progression) in patients with liver cancer that can be removed by surgery (resectable). The development of novel cancer biomarkers for liver cancer may help in clinical decision making and lead to improvements in patient outcomes by facilitating prediction of the response to specific treatments, improved monitoring of patients on treatment, and better prognostication of patient outcomes, thus improving stratification for clinical trials.
Official title: Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Hepatocellular Carcinoma (ATHENA)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
36
Start Date
2021-11-06
Completion Date
2026-04-01
Last Updated
2025-06-12
Healthy Volunteers
No
Conditions
Interventions
Biospecimen Collection
Undergo collection of blood sample
Electronic Health Record Review
Review of medical records
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States